Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season

Richard Pebody, B. Sile, F. Warburton, M. Sinnathamby, C. Tsang, Hongxin Zhao, Joanna Ellis, Nicholas Andrews

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

The United Kingdom is introducing a universal annual influenza vaccination programme for children. Live attenuated influenza vaccine (LAIV) effectiveness (VE) against laboratory-confirmed influenza hospitalisation in 2 to 6 year-olds in England was measured in 2015/16 using the screening method. VE adjusted for age, geography and month was 54.5% (95% confidence interval (CI): 31.5% to 68.4%) for all influenza types combined; 48.3% (95% CI: 16.9% to 67.8%) for A(H1N1)pdm09 and 70.6% (95% CI: 33.2% to 87.1%) for B. The findings support on-going programme roll-out.

Original languageEnglish
JournalEurosurveillance
Volume22
Issue number4
DOIs
Publication statusPublished - Jan 2017

Fingerprint

Dive into the research topics of 'Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season'. Together they form a unique fingerprint.

Cite this